MedTrace Logo

Bone and Muscle Oxygenation in Military Test Pilots

NCT07787143 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-08-26

No results posted yet for this study

Summary

This prospective, single-group interventional pilot study will evaluate the effects of a 12-week resistance and core stabilization exercise program on bone mineral density and resting muscle oxygenation in male military test pilots with low baseline bone mineral density. Participants will complete a supervised exercise program five days per week for 12 weeks while continuing their routine flight duties. Bone mineral density will be assessed using dual-energy X-ray absorptiometry, and resting muscle oxygenation will be evaluated in the vastus lateralis and rectus abdominis using near-infrared spectroscopy before and after the intervention. The study aims to characterize preliminary skeletal and muscle oxygenation responses to structured exercise in this specialized aviation population.

Conditions

  • Low Bone Mineral Density
  • Muscle Oxygenation

Interventions

BEHAVIORAL

Supervised Resistance and Core Stabilization Exercise Program

Participants will undergo a 12-week physiotherapist-supervised resistance and core stabilization exercise program performed five days per week for approximately 120 minutes per session. The program will progress through three phases: adaptation (weeks 1-4, approximately 60% of one-repetition maximum \[1RM\]), strength development (weeks 5-8, 70-75% 1RM), and high-load neuromuscular control (weeks 9-12, 80-85% 1RM). The intervention will include multi-joint lower-extremity exercises (squat and deadlift), core stabilization exercises (plank, side plank, bird-dog, dead bug, and posterior pelvic tilt), and posterior-chain exercises (lunges, hip thrusts, and back extensions). Exercise tempo and rest intervals will be standardized, and training loads will be individually adjusted according to participant performance and tolerance

Sponsors & Collaborators

  • Emine Merve Ersever

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-15
Primary Completion
2026-12-15
Completion
2027-02-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07787143 on ClinicalTrials.gov